Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Triferic AVNU contains iron in the form of ferric pyrophosphate citrate. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is indicated as an iron replacement product indicated for adult patients with HDD-CKD.
Lead Product(s): Ferric Pyrophosphate Citrate
Therapeutic Area: Nephrology Product Name: Triferic AVNU
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Rockwell Medical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 27, 2023